Infliximab Management Complex Regional Pain Syndrome

The role of inflammatory mechanisms in the pathogenesis of CRPS is important and that makes it a target that must meet every day. Infliximab is a molecule that has been used in the management of CRPS and published case reports and two studies showing improvement in range of motion, differences in temperature and decrease pain persist even phenomena of peripheral and Central after a few months; as same adverse reactions have been reported including appearance of CRPS in patients who received other necessary conditions and use with caution. The information is so far low level of evidence for such studies from which it was generated so it is necessary to have higher quality studies to obtain more solid conclusions.